BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8363826)

  • 21. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the screening error rate from the observed detection rates in repeated cercival cytology.
    Coppleson LW; Brown B
    Am J Obstet Gynecol; 1974 Aug; 119(7):953-8. PubMed ID: 4841153
    [No Abstract]   [Full Text] [Related]  

  • 24. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
    Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
    Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality control in cervical cytology.
    Husain OA; Butler EB; Evans DM; Macgregor JE; Yule R
    J Clin Pathol; 1974 Dec; 27(12):935-44. PubMed ID: 4141708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.
    van de Nieuwenhof HP; Massuger LF; de Hullu JA; van Ham MA; van Dijck JA; Siebers AG; Bekkers RL
    Br J Cancer; 2008 Jan; 98(1):165-7. PubMed ID: 18182979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
    Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
    Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cervical smears in the study of intraepithelial neoplasms].
    Varleta L; Salas O; Toledo P; Iglesias J; Tisné L; Dabancens A; Lorenzetti L
    Rev Chil Obstet Ginecol; 1978; 43(6):344-51. PubMed ID: 550214
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
    Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
    PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical smear histories of 585 women with biopsy-proven carcinoma in situ.
    Bergeron C; Debaque H; Ayivi J; Amaizo S; Fagnani F
    Acta Cytol; 1997; 41(6):1676-80. PubMed ID: 9390123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical or suspicious cervical smears. An aggressive diagnostic approach.
    Nyirjesy I
    JAMA; 1972 Nov; 222(6):691-3. PubMed ID: 4677898
    [No Abstract]   [Full Text] [Related]  

  • 34. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of endocervical cells in the diagnosis of cervical epithelial changes.
    Elias A; Linthorst G; Bekker B; Vooijs PG
    Acta Cytol; 1983; 27(3):225-9. PubMed ID: 6575534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G; Cariaggi P; Ottaviano M; Marchionni M; Mincione G; Bartoloni St Omer F
    Minerva Ginecol; 1975 May; 27(5):418-21. PubMed ID: 1134695
    [No Abstract]   [Full Text] [Related]  

  • 37. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z; Austin RM; Guo M; Zhao C
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri.
    Krumins I; Young Q; Pacey F; Bousfield L; Mulhearn L
    Acta Cytol; 1977; 21(2):320-9. PubMed ID: 266347
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Screening for cervical cancer.
    Lancet; 1974 Jun; 1(7868):1221. PubMed ID: 4134347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.